Cellular Senescence in Adrenocortical Biology and Its Disorders
Open Access
Abstract
Cellular senescence is considered a physiological process along with aging and has recently been reported to be involved in the pathogenesis of many age-related disorders. Cellular senescence was first found in human fibroblasts and gradually explored in many other organs, including endocrine organs. The adrenal cortex is essential for the maintenance of blood volume, carbohydrate metabolism, reaction to stress and the development of sexual characteristics. Recently, the adrenal cortex was reported to harbor some obvious age-dependent features. For instance, the circulating levels of aldosterone and adrenal androgen gradually descend, whereas those of cortisol increase with aging. The detailed mechanisms have remained unknown, but cellular senescence was considered to play an essential role in age-related changes of the adrenal cortex. Recent studies have demonstrated that the senescent phenotype of zona glomerulosa (ZG) acts in association with reduced aldosterone production in both physiological and pathological aldosterone-producing cells, whereas senescent cortical-producing cells seemed not to have a suppressed cortisol-producing ability. In addition, accumulated lipofuscin formation, telomere shortening and cellular atrophy in zona reticularis cells during aging may account for the age-dependent decline in adrenal androgen levels. In adrenocortical disorders, including both aldosterone-producing adenoma (APA) and cortisol-producing adenoma (CPA), different cellular subtypes of tumor cells presented divergent senescent phenotypes, whereby compact cells in both APA and CPA harbored more senescent phenotypes than clear cells. Autonomous cortisol production from CPA reinforced a local cellular senescence that was more severe than that in APA. Adrenocortical carcinoma (ACC) was also reported to harbor oncogene-induced senescence, which compensatorily follows carcinogenesis and tumor progress. Adrenocortical steroids can induce not only a local senescence but also a periphery senescence in many other tissues. Therefore, herein, we systemically review the recent advances related to cellular senescence in adrenocortical biology and its associated disorders.Keywords
Funding Information
- National Natural Science Foundation of China (Nos. 81970648)
- International Cooperation Project of the Department of Science and Technology of Jilin Province (Nos. 20180101162JC, 20190701049GH)
This publication has 206 references indexed in Scilit:
- Glucocorticoid Receptor and Sequential P53 Activation by Dexamethasone Mediates Apoptosis and Cell Cycle Arrest of Osteoblastic MC3T3-E1 CellsPLOS ONE, 2012
- Towards an understanding of the role of p53 in adrenocortical carcinogenesisMolecular and Cellular Endocrinology, 2012
- Cellular senescence and tumor suppressor gene p16International Journal of Cancer, 2011
- Pulmonary Artery Smooth Muscle Cell Senescence Is a Pathogenic Mechanism for Pulmonary Hypertension in Chronic Lung DiseaseCirculation Research, 2011
- Inflammatory networks during cellular senescence: causes and consequencesTrends in Molecular Medicine, 2010
- The PPARγ Agonist Pioglitazone Ameliorates Aging-Related Progressive Renal InjuryJournal of the American Society of Nephrology, 2009
- The cell cycle and acute kidney injuryKidney International, 2009
- Adrenal androgen dehydroepiandrosterone sulfate inhibits vascular remodeling following arterial injuryAtherosclerosis, 2009
- p53 in health and diseaseNature Reviews Molecular Cell Biology, 2007
- Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidneyKidney International, 2004